New pain pill shows promise for bunion surgery recovery

NCT ID NCT06017999

First seen Nov 17, 2025 · Last updated May 12, 2026 · Updated 25 times

Summary

This study tested an experimental pain medication called XG005 in 450 adults who had bunion surgery. Participants received either a low dose, high dose, or a placebo (sugar pill) and reported their pain levels over 48 hours. The goal was to see if XG005 could safely reduce pain after surgery better than a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Arizona Research Center

    Phoenix, Arizona, 85053, United States

  • Clinical Pharmacology of Miami

    Hialeah, Florida, 33014, United States

  • Endeavor Clinical Trials

    San Antonio, Texas, 78229, United States

  • First Surgical Hospital

    Bellaire, Texas, 77401, United States

  • Legent Orthopedic Hospital

    Carrollton, Texas, 75006, United States

  • Memorial Hermann Village

    Houston, Texas, 77043, United States

  • Midwest Clinical Research Center

    Dayton, Ohio, 45417, United States

  • Pacific Research Network

    San Diego, California, 92128, United States

Conditions

Explore the condition pages connected to this study.